SUMMARY The water-soluble (BI, B2, B6, C, folic acid) and fat-soluble vitamin (A, carotene, E, and D) status of 36 patients with cystic fibrosis was assessed and compared with a control group of 21 age-matched normal children. Twenty-seven of the patients were receiving vitamin supplements (except folic acid and vitamin E) at the time of investigation. Vitamin BI, B2, and B6 status was adequate in all patients, and there was little evidence of folic acid deficiency. Vitamin C stores might not have been adequate in some of these patients, despite daily supplements with 50 mg of the vitamin. Steatorrhoea, often severe, was present in most of them. Serum carotene and vitamin E concentrations were low in over 90 % of patients and were related to the severity of steatorrhoea. Vitamin A was low in over 40% of the patients despite daily vitamin supplements of 4000 IU and correlated with the serum retinol-binding protein level. Serum 25-OH cholecalciferol was low in some patients whether or not they were receiving a daily supplement of 400 IU vitamin D. In a short-term supplementation trial with water-miscible preparations of vitamins A and E in 14 patients, the serum levels of both vitamins responded well to 2 weeks of treatment with 50 mg vitamin E and 4000 IU vitamin A. Except for serum vitamin A, which was lowest in patients with the poorest clinical grading, the other vitamins were not influenced by the clinical grade of the patients.
Cystic fibrosis occurs in about 1/2000 of live births in white Europeans, the majority of new cases now being diagnosed soon after birth. Life expectancy has been greatly improved by early vigorous treatment,'-4 and has resulted in an increasing population of patients who will require life-long medical care. Pancreatic insufficiency is present in over 80 % of patients with cystic fibrosis.1 The resulting fat malabsorption is often severe and may not respond well to pancreatic replacement.5 6 Although gastrointestinal absorption of fat-soluble vitamins is impaired in patients with steatorrhoea and correlates with its severity,7 clinical deficiency, manifested by bone disease (rickets) or severe bleeding, is rare in cystic fibrosis, although it does occur.8 9 Symptoms are mainly a consequence of pulmonary infection and pancreatic insufficiency and there is great variation in the presentation and severity of symptoms.10 Malnutrition can be a major complication of cystic fibrosis,"1 12 resulting in the main from pancreatic insufficiency,13 and in younger children is manifested in poor weight gain and growth. It with cystic fibrosis, from the time of diagnosis, are given a daily multivitamin preparation containing water-soluble vitamins as well as the fat-soluble vitamins A and D. Vitamins E and K are not consistently supplemented. The quantity of vitamins given is generally twice the recommended intake for age, '6 17 but this appears to be quite arbitrary, and there is little evidence that these supplements are adequate except for vitamin A, which has been widely studied. Despite prolonged supplementation, deficiencies of vitamin A are common.'8 19 A need therefore exists to assess the vitamin status of patients with cystic fibrosis during treatment, and to determine if present practice of vitamin supplementation is adequate.
The purpose of the present study was to measure a wide spectrum of blood vitamin levels in patients with cystic fibrosis. The adequacy of conventional vitamin supplements was assessed, and the level of fat-soluble vitamins was related to the severity of fat 708 malabsorption. The effect of short-term supplementation with water-miscible forms of vitamins A and E was also assessed.
Patients studied
Thirty-six patients with cystic fibrosis (19 
Faecalfat
Polyethylene glycol 4000 was used as a nonabsorbable marker and determined by the method of Hyden.30 Polyethylene glycol 4000 was administered in a dose of 250 mg 3-times daily one dose with each main meal for 7 days and faeces collected on day 6-7. Faecal fat was determined on 2-day faecal collections31 by the method of van de Kamer et al. 32 and corrected for polyethylene glycol recovery.
Assays for vitamins B2, B6, and C were performed on the same day as the specimen was received; all other assays were performed within one week of collection. additional vitamin C and their levels were similar to those of the supplemented group. The clinical state as assessed by the Shwachman score had little relation to leucocyte vitamin C levels (Fig. 2) . Patients were arbitrarily divided into two groups, above and below a score of 75, and the range of values in each group was similar (Fig. 2) Vitamin A. Despite supplementation with up to 4000 IU a day, a high proportion of patients had low serum vitamin A levels (Fig. 3) Response to supplements. The response of the serum vitamin A and E to oral supplementation for 2 weeks with fairly small doses of water-miscible preparations is shown in Fig. 5 . The level of both vitamins rose in all 14 patients. The mean serum vitamin A increased from 1-68 to 3 09 ,umol/l, while the mean serum vitamin E level increased from 7-33 to 13-0 Vmol/l, both increases being highly significant (P<0-01). The increase in vitamin A in individual patients was not related either to the severity of steatorrhoea or to the initial level of RBP. The increase in serum vitamin E was not related to the severity of steatorrhoea or to the level of 5-lipoprotein. 
